(Q46120196)

19 December 2017

title

Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-Trial (English)

1 reference

19 December 2017

author

Paul W. Armstrong

6

1 reference

19 December 2017

Christopher B. Granger

7

object named as

C B Granger

1 reference

19 December 2017

author name string

B G Angeja

1

1 reference

19 December 2017

J H Alexander

2

1 reference

19 December 2017

R Chin

3

1 reference

19 December 2017

X Li

4

1 reference

19 December 2017

H V Barron

5

1 reference

19 December 2017

F Van de Werf

8

1 reference

19 December 2017

C M Gibson

9

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

19 December 2017

American Journal of Cardiology

published in

1 reference

19 December 2017

volume

88

1 reference

19 December 2017

issue

11

1 reference

19 December 2017

page(s)

1240-1245

1 reference

19 December 2017

A faster-acting and more potent form of tissue plasminogen activator

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902084-7

TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902084-7

Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902084-7

Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902084-7

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902084-7

Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902084-7

Bolus fibrinolysis: risk, benefit, and opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902084-7

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902084-7

1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Comm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902084-7

Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902084-7

Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902084-7

Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902084-7

Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902084-7

Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902084-7

Time to therapy and salvage in myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902084-7

10.1016/S0002-9149(01)02084-7

7 January 2021

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017